RNHD | Chan: Exploiting dysregulated ribosome homeostasis for cancer therapy
Sponsor(s):
Pharmacology and Cancer Biology
Wednesday, April 23, 2025
12:00 pm - 1:00 pm
Edmond M. Chan, MD, Assistant Professor of Medicine at Columbia University Irving Medical Center
PCB Works in Progress
Sponsor(s):
Pharmacology and Cancer Biology, Molecular Cancer Biology (MCB), and School of Medicine (SOM)
Friday, April 25, 2025
12:00 pm - 1:00 pm
Tatiana Prioleau & Xiaojuan Ran, PhD
RNHD | Cambronne: Localized Real-time Sensors for Metabolic Signaling
Wednesday, April 30, 2025
12:00 pm - 1:00 pm
Lulu Ang Cambronne, PhD, Assistant Professor, Department of Molecular Biosciences in the College of Natural Sciences at the University of Texas at Austin
PCB | Nacev: Decoding the Epigenome in ATRX-Deficient Sarcomas: Can We Move Towards Precision Therapies?
Sponsor(s):
Pharmacology and Cancer Biology, Molecular Cancer Biology (MCB), and School of Medicine (SOM)
Wednesday, May 07, 2025
12:00 pm - 1:00 pm
Benjamin Nacev, MD, PhD, Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Department of Pathology, University of Pittsburgh School of Medicine, Member, UPMC Hillman Cancer Center
PCB | Kappei: Hyperactivation of the ALT pathway causes persistent chromatin bridge formation and telomere-driven genomic instability
Sponsor(s):
Pharmacology and Cancer Biology, Molecular Cancer Biology (MCB), and School of Medicine (SOM)
Friday, May 09, 2025
12:00 pm - 1:00 pm
Dennis Kappei, PhD
